Stabilność mRNA i ekspresja genów

mRNA stability directly controls how long proteins are produced after transcription stops. Stable mRNAs with half-lives of several hours allow continuous protein synthesis long after the gene stops being transcribed. Unstable mRNAs with half-lives under 30 minutes are rapidly degraded, limiting translation to brief periods unless transcription remains active. This enables organisms to quickly halt production of unnecessary proteins.

The deadenylation-dependent pathway is the most common mRNA degradation mechanism. A deadenylating nuclease complex removes adenines from the poly-A tail in the 3' to 5' direction. When the tail shortens below 15 residues, protective proteins dissociate, exposing the 5' cap to decapping enzymes. The cytoplasmic exosome complex then degrades the unprotected mRNA from both ends.

The poly-A tail protects mRNA from exonuclease degradation and serves as a binding site for stabilizing proteins. When the poly-A tail shortens to fewer than 15-20 nucleotides, protective proteins cannot bind effectively, destabilizing the mRNA structure. This exposes the 5' cap to decapping enzymes, triggering rapid degradation. AU-rich sequences in the 3' untranslated region also influence how quickly the poly-A tail is removed.

In the deadenylation-independent pathway, decapping enzymes directly remove the 5' cap without requiring poly-A tail shortening. An exonuclease then degrades the unprotected mRNA from the 5' to 3' direction. This pathway bypasses the need for adenine removal, allowing rapid mRNA degradation through alternative mechanisms when the standard deadenylation route is blocked.

AU-rich sequences in the 3' untranslated region act as binding sites for mRNA-destabilizing and mRNA-stabilizing proteins. When destabilizing proteins bind these sequences, they promote rapid deadenylation and degradation. Stabilizing proteins compete for the same binding sites, decreasing degradation rates. This competition between opposing protein factors allows cells to dynamically control mRNA half-life based on cellular needs.

P bodies, or processing bodies, are aggregated protein complexes where mRNA degradation occurs. These structures contain enzymes involved in decapping and 5' to 3' mRNA degradation. P bodies concentrate the molecular machinery needed for efficient mRNA turnover, allowing cells to regulate gene expression by controlling where and when mRNAs are degraded.

Internal cleavage is the least common mRNA degradation pathway, involving specific endonucleases that cut mRNA at internal sites. This cleavage creates mRNA fragments with unprotected 5' and 3' ends. Exonucleases then rapidly degrade these fragments from both directions, completing the degradation process. This mechanism provides an alternative route when standard deadenylation and decapping pathways are unavailable.